Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences - 27 Year Stock Price History | GILD

Historical daily share price chart and data for Gilead Sciences since 1992 adjusted for splits. The latest closing stock price for Gilead Sciences as of August 23, 2019 is 62.51.
  • The all-time high Gilead Sciences stock price is 111.59, which is 78.5% above the current share price.
  • The Gilead Sciences 52-week high stock price is 78.34, which is 25.3% above the current share price.
  • The Gilead Sciences 52-week low stock price is 60.54, which is 3.2% below the current share price.
  • The average Gilead Sciences stock price for the last 52 weeks is 67.60.
  
Gilead Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 66.0217 63.4400 70.0500 61.8700 62.5100 -0.06%
2018 72.4550 71.8230 86.0713 60.5400 62.5500 -9.92%
2017 69.0094 69.8347 81.7515 60.8436 69.4386 2.97%
2016 77.6107 90.2269 94.6147 67.1529 67.4334 -27.61%
2015 97.2518 86.3445 111.5870 86.3445 93.1544 8.63%
2014 81.4943 68.4224 103.9118 59.5705 85.7531 25.51%
2013 51.0011 34.1430 68.4133 34.0929 68.3223 104.49%
2012 25.7100 19.0411 34.7252 19.0411 33.4106 79.45%
2011 18.1622 16.6393 19.6552 16.0753 18.6181 12.94%
2010 17.8632 19.6961 22.4936 14.4787 16.4847 -16.25%
2009 20.9767 23.7354 24.0174 18.8500 19.6825 -15.39%
2008 22.3728 20.6241 25.9734 17.0442 23.2623 11.15%
2007 18.0039 14.3627 21.7158 14.2672 20.9288 41.72%
2006 14.0807 12.4408 15.8638 12.2248 14.7675 23.51%
2005 9.6150 7.8989 12.6524 7.0597 11.9564 50.24%
2004 7.3176 6.5980 8.8792 5.8861 7.9580 20.08%
2003 5.8553 3.9677 7.9592 3.6731 6.6275 71.41%
2002 3.8727 3.4929 4.5158 3.0192 3.8664 3.47%
2001 2.8512 2.1075 4.1058 1.5369 3.7368 58.47%
2000 2.1420 1.6009 3.3035 1.2350 2.3580 53.23%
1999 1.5176 1.1301 2.6263 1.0164 1.5389 31.83%
1998 0.9068 1.0840 1.2296 0.5188 1.1673 7.35%
1997 0.8913 0.6965 1.3115 0.6149 1.0874 53.00%
1996 0.8062 0.9274 1.1585 0.4904 0.7107 -21.88%
1995 0.5241 0.2665 0.9169 0.2665 0.9098 236.84%
1994 0.2860 0.3412 0.3980 0.1990 0.2701 -20.84%
1993 0.4206 0.5188 0.5439 0.3056 0.3412 -37.66%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $81.218B $22.127B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.303B 13.93
Celgene (CELG) United States $67.812B 10.49
Vertex Pharmaceuticals (VRTX) United States $47.911B 51.78
Biogen (BIIB) United States $43.009B 7.64
Illumina (ILMN) United States $42.704B 50.17
CSL (CSLLY) Australia $36.183B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.705B 14.84
Alexion Pharmaceuticals (ALXN) United States $25.750B 13.57
Incyte (INCY) United States $18.511B 54.47
Exact Sciences (EXAS) United States $15.439B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.038B 0.00
Seattle Genetics (SGEN) United States $12.933B 0.00
Genmab (GNMSF) Denmark $12.462B 70.36
Bio-Rad Laboratories (BIO.B) United States $9.886B 52.99
Guardant Health (GH) United States $9.702B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.271B 0.00
Galapagos (GLPG) Belgium $8.686B 0.00
QIAGEN (QGEN) Netherlands $7.848B 25.78
Sarepta Therapeutics (SRPT) United States $7.546B 0.00
Bio-Techne Corp (TECH) United States $7.317B 50.58
BeiGene (BGNE) Cayman Islands $6.934B 0.00
Bluebird Bio (BLUE) United States $6.539B 0.00
Exelixis (EXEL) United States $6.512B 16.93
Amarin (AMRN) Ireland $5.733B 0.00
Horizon Pharma Public (HZNP) Ireland $5.215B 13.26
Ascendis Pharma (ASND) Denmark $4.896B 0.00
Repligen (RGEN) United States $4.812B 93.38
Moderna (MRNA) United States $4.718B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.460B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.310B 0.00
MorphoSys AG (MOR) Germany $3.964B 0.00
Blueprint Medicines (BPMC) United States $3.904B 0.00
China Biologic Products (CBPO) China $3.903B 24.37
Spark Therapeutics (ONCE) United States $3.898B 0.00
Mirati Therapeutics (MRTX) United States $3.613B 0.00
Alkermes (ALKS) Ireland $3.495B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.389B 0.00
Arena Pharmaceuticals (ARNA) United States $2.840B 6.10
Genomic Health (GHDX) United States $2.772B 51.99
NeoGenomics (NEO) United States $2.725B 145.78
Medicines (MDCO) United States $2.722B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.677B 0.00
Immunomedics (IMMU) United States $2.674B 0.00
Amicus Therapeutics (FOLD) United States $2.618B 0.00
MyoKardia (MYOK) United States $2.570B 0.00
Acceleron Pharma (XLRN) United States $2.494B 0.00
Halozyme Therapeutics (HALO) United States $2.454B 0.00
Reata Pharmaceuticals (RETA) United States $2.261B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.206B 0.00
Emergent Biosolutions (EBS) United States $2.172B 32.64
UniQure (QURE) Netherlands $2.137B 0.00
Zai Lab (ZLAB) China $2.071B 0.00
Akcea Therapeutics (AKCA) United States $2.052B 0.00
Cambrex (CBM) United States $1.994B 25.20
Myriad Genetics (MYGN) United States $1.853B 19.45
Ligand Pharmaceuticals (LGND) United States $1.853B 23.43
Denali Therapeutics (DNLI) United States $1.780B 0.00
Coherus BioSciences (CHRS) United States $1.529B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.504B 0.00
Insmed (INSM) United States $1.472B 0.00
RA PHARMCTL INC (RARX) United States $1.405B 0.00
REGENXBIO (RGNX) United States $1.354B 0.00
Sangamo Therapeutics (SGMO) United States $1.331B 0.00
Editas Medicine (EDIT) United States $1.281B 0.00
Fate Therapeutics (FATE) United States $1.261B 0.00
Epizyme (EPZM) United States $1.236B 0.00
Athenex (ATNX) United States $1.217B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.215B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.209B 0.00
Innoviva (INVA) United States $1.172B 3.38
AnaptysBio (ANAB) United States $1.171B 0.00
Alector (ALEC) United States $1.090B 0.00
Twist Bioscience (TWST) United States $0.999B 0.00
Zymeworks (ZYME) Canada $0.999B 0.00
Cara Therapeutics (CARA) United States $0.964B 0.00
Principia Biopharma (PRNB) United States $0.954B 497.38
Dicerna Pharmaceuticals (DRNA) United States $0.927B 0.00
Intellia Therapeutics (NTLA) United States $0.836B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.834B 0.00
Cytokineticsorporated (CYTK) United States $0.818B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.816B 0.00
ANI Pharmaceuticals (ANIP) United States $0.811B 13.55
Arvinas (ARVN) United States $0.809B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.802B 28.96
Anika Therapeutics (ANIK) United States $0.785B 27.80
Alder BioPharmaceuticals (ALDR) United States $0.785B 0.00
Codexis (CDXS) United States $0.769B 0.00
Vericel (VCEL) United States $0.767B 0.00
Adverum Biotechnologies (ADVM) United States $0.764B 0.00
Pharming Group (PHGUF) Netherlands $0.759B 0.00
WAVE Life Sciences (WVE) Singapore $0.755B 0.00
Retrophin (RTRX) United States $0.747B 0.00
Zealand Pharma (ZLDPF) Denmark $0.664B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.662B 0.00
Zealand Pharma (ZEAL) Denmark $0.647B 7.51
MiMedx (MDXG) United States $0.618B 0.00
Stemline Therapeutics (STML) United States $0.603B 0.00
Heska (HSKA) United States $0.586B 75.90
DBV Technologies S.A (DBVT) France $0.569B 0.00
Cellectis S.A (CLLS) France $0.531B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.517B 0.00
PHARMA MAR SA (PHMMF) Spain $0.508B 0.00
Revance Therapeutics (RVNC) United States $0.495B 0.00
Intra-Cellular Therapies (ITCI) United States $0.491B 0.00
Precision BioSciences (DTIL) United States $0.472B 0.00
Syros Pharmaceuticals (SYRS) United States $0.466B 0.00
Mesoblast (MESO) Australia $0.461B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.448B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.439B 0.00
CytomX Therapeutics (CTMX) United States $0.429B 0.00
Puma Biotechnology (PBYI) United States $0.426B 0.00
Merus (MRUS) Netherlands $0.410B 0.00
Agenus (AGEN) United States $0.405B 0.00
BioDelivery Sciences (BDSI) United States $0.398B 0.00
Avid Bioservices (CDMO) United States $0.397B 0.00
Gritstone Oncology (GRTS) United States $0.385B 0.00
AC Immune SA (ACIU) Switzerland $0.381B 28.20
Scholar Rock Holding (SRRK) United States $0.374B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.361B 0.00
Kadmon Holdings (KDMN) United States $0.340B 0.00
Albireo Pharma (ALBO) United States $0.335B 0.00
Clovis Oncology (CLVS) United States $0.331B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Arcus Biosciences (RCUS) United States $0.320B 0.00
Theratechnologies (THERF) Canada $0.319B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Protagonist Therapeutics (PTGX) United States $0.311B 0.00
Kindred Biosciences (KIN) United States $0.305B 0.00
Sorrento Therapeutics (SRNE) United States $0.303B 0.00
Prothena (PRTA) Ireland $0.301B 0.00
PDL BioPharma (PDLI) United States $0.297B 7.65
Dynavax Technologies (DVAX) United States $0.294B 0.00
Cel-Sci (CVM) United States $0.293B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.272B 0.00
Geron (GERN) United States $0.268B 0.00
Seres Therapeutics (MCRB) United States $0.259B 0.00
Senesco Technologies (ELOX) United States $0.248B 0.00
PHASEBIO PHARMA (PHAS) United States $0.247B 0.00
ADMA Biologics Inc (ADMA) United States $0.241B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.238B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.236B 0.00
Inovio Pharmaceuticals (INO) United States $0.234B 0.00
Cellular Biomedicine (CBMG) United States $0.233B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.232B 0.00
ChromaDex (CDXC) United States $0.223B 0.00
Pfenex (PFNX) United States $0.220B 0.00
Kamada (KMDA) Israel $0.217B 8.31
Athersys (ATHX) United States $0.214B 0.00
Five Prime Therapeutics (FPRX) United States $0.213B 0.00
MannKind (MNKD) United States $0.212B 0.00
Compugen (CGEN) Israel $0.204B 0.00
Palatin Technologies (PTN) United States $0.196B 0.00
CorMedix Inc (CRMD) United States $0.195B 0.00
Sutro Biopharma (STRO) United States $0.193B 0.00
Prometic Life Sciences (PFSCF) Canada $0.189B 0.00
Cue Biopharma (CUE) United States $0.185B 0.00
Spero Therapeutics (SPRO) United States $0.185B 0.00
Affimed (AFMD) Germany $0.175B 0.00
Dyadic (DYAI) United States $0.174B 0.00
Cerecor (CERC) United States $0.169B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.165B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Novavax (NVAX) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) $0.163B 0.00
Emmaus Life Sciences (EMMA) United States $0.160B 0.00
Arsanis (XFOR) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.156B 0.00
XOMA (XOMA) United States $0.155B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.153B 0.00
OSMOTICA PHARM (OSMT) United States $0.153B 0.00
Acorda Therapeutics (ACOR) United States $0.151B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.150B 0.00
Alcobra (ARCT) United States $0.147B 0.00
Nicox SA (NICXF) France $0.147B 0.00
BioTime (LCTX) United States $0.144B 9.60
Strongbridge Biopharma (SBBP) United States $0.141B 5.78
Adocia (ADOCY) France $0.140B 0.00
Windtree Therapeutics (WINT) United States $0.133B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.132B 0.00
NantKwest (NK) United States $0.132B 0.00
Mersana Therapeutics (MRSN) United States $0.131B 0.00
Celyad SA (CYAD) Belgium $0.128B 0.00
Fortress Biotech (FBIO) United States $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.124B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.119B 0.00
Northwest Biotherapeutics (NWBO) United States $0.116B 0.00
TOCAGEN INC (TOCA) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.114B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.112B 0.00
Menlo Therapeutics (MNLO) United States $0.109B 0.00
Abeona Therapeutics (ABEO) United States $0.109B 0.00
Aduro Biotech (ADRO) United States $0.108B 0.00
Aptinyx (APTX) United States $0.106B 0.00
Liquidia Technologies (LQDA) United States $0.104B 0.00
Verastem (VSTM) United States $0.103B 0.00
Synlogic (SYBX) United States $0.102B 0.00
OvaScience (MLND) United States $0.097B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.095B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.088B 0.00
Catalyst Biosciences (CBIO) United States $0.087B 0.00
Trevena (TRVN) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.081B 0.00
Selecta Biosciences (SELB) United States $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.080B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.079B 0.00
Vaccinex (VCNX) United States $0.077B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.072B 0.00
ARAVIVE, INC (ARAV) United States $0.069B 0.00
AquaBounty Technologies (AQB) United States $0.067B 0.00
Curis (CRIS) United States $0.067B 0.00
Idera Pharmaceuticals (IDRA) United States $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.066B 0.00
Unum Therapeutics (UMRX) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.062B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
VBI Vaccines (VBIV) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.055B 0.00
Applied Genetic Technologies (AGTC) United States $0.055B 30.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
AIT Therapeutics (XAIR) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.052B 0.00
Ophthotech (ISEE) United States $0.048B 0.00
Clearside Biomedical (CLSD) United States $0.048B 0.00
VIVUS (VVUS) United States $0.042B 0.00
Signal Genetics (MGEN) United States $0.042B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Celsion (CLSN) United States $0.041B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.037B 0.00
Proteostasis Therapeutics (PTI) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
AEterna Zentaris (AEZS) United States $0.034B 0.00
Entera Bio (ENTX) Israel $0.034B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
VistaGen Therapeutics (VTGN) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Vical (VICL) United States $0.020B 0.00
Bionano Genomics (BNGO) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.27
CollPlant Holdings (CLGN) Israel $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
IBio (IBIO) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Novelion Therapeutics (NVLN) Canada $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
AmpliPhi Biosciences (ARMP) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
IMMURON (IMRN) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Hemispherx BioPharma (HEB) United States $0.005B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
Neuralstem (CUR) United States $0.002B 0.00